Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT (RIC HSCT NMD)

    ... pulmonologist. For adult patients DLCO (corrected for hemoglobin ) should be > 50% of predicted, if the DLCO can be obtained. ...

    Clinical Trial last updated 06/13/2016 - 2:18pm.

  2. Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?

    ... significant association between ESA response, post-ESA hemoglobin ≥100 g/L, and post-ESA ferritin <1000 ng/mL (P = 0.0003 ...

    Research Article last updated 12/09/2015 - 8:52am.

  3. Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

    ... be willing to accept/continue transfusions to treat low hemoglobin levels Subjects must have a life expectancy of > 6 months ...

    Clinical Trial last updated 06/06/2016 - 2:18pm.

  4. Genetic Polymorphism of the Complement Receptor-1 (CR1) Gene Correlates with the Clinical Response to Eculizumab of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

    ... with PNH who go on Eculizumab have an increase in their hemoglobin up to the normal range and never require another transfusion. Other patients will have an increase in their hemoglobin and will be able to discontinue transfusions, but will still be ...

    Research Review last updated 05/02/2016 - 9:25am.

  5. Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes

    ... and time to AML progression. Achievement of RBC-TI and hemoglobin response was additionally associated with HRQOL benefits. ...

    Research Article last updated 12/08/2015 - 1:06pm.

  6. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

    ... lung for carbon monoxide (DLCO) ≥ 40% (adjusted for hemoglobin ) and forced expiratory volume in one second (FEV1) ≥ 50% ...

    Clinical Trial last updated 06/06/2016 - 1:59pm.

  7. AML Therapy With Irradiated Allogeneic Cells

    ... platelet count 150,000 to 440,000/mm^3 DONOR: hemoglobin / hematocrit ; 12.5-18 g/dl, 38 to 54% DONOR: not ...

    Clinical Trial last updated 06/13/2016 - 3:14pm.

  8. Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD in Children

    ... of the lung for carbon monoxide (DLCO) (corrected for hemoglobin ) of < 60% predicted; patients who are unable to perform ...

    Clinical Trial last updated 06/13/2016 - 2:29pm.

  9. Disease Won't Run My Life

    ... blood values do not support life.”  It turned out my hemoglobin was under three (12-15 normal), my white cells about .1 (3.5 – ... the initial ATG treatment. My counts stayed steady  – hemoglobin in the 10 -12 range, white cells almost normal, and platelets ...

    Patient Chronicle last updated 05/10/2016 - 3:36pm.

  10. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

    ... the lung for carbon monoxide (DLCO) >50% (adjusted for hemoglobin ), and forced expiratory volume in one second (FEV1) or forced ...

    Clinical Trial last updated 06/06/2016 - 1:36pm.